JPRN-UMIN000019089招募中未知
A study of haploidentical transplantation with post-transplant cyclophosphamide - A study of haploidentical transplantation with post-transplant cyclophosphamide
Department of Hematology, Kanazawa University Hospital0 个研究点目标入组 40 人开始时间: 2015年9月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients who are positive for HBs antigen, HCV antibody, or HIV antibody. 2. Patients with active other malignancies. 3. Women who are pregnant, of childbearing potential, or lactating. 4. Patients who experienced serious hypersensitivity or anaphylaxis to cyclophosphamide. 5. patients who are not eligble for this study at the discretion of the investigator.
研究者
相似试验
已完成
不适用
A study of haploidentical transplantation with post-transplant cyclophosphamide and prophylactic donor lymphocyte infusions.AML,ALL,MDS,NHL,CML Neuroblastoma,Rhabdomyosarcoma,Ewing sarcomaJPRN-UMIN000030767Department of Pediatrics, Kanazawa University Hospital8
已完成
不适用
Haploidentical transplantation with post-transplant cyclophosphamideJPRN-UMIN000018730Division of Hematology & Oncology, Department of Medicine, Kurume University School of Medicine21
已完成
不适用
A phase II study of haploidentical transplantation with post-transplantation cyclophosphamide following myeloablative conditioninghematologic malignanciesJPRN-UMIN000020655JSCT42
已完成
不适用
A phase II study of haploidentical transplantation with post-transplantation cyclophosphamide following reduced-intensity conditioningJPRN-UMIN000020656JSCT36
已完成
不适用
A phase II study of haploidentical transplantation with post-transplantation cyclophosphamide following reduced-intensity conditioningJPRN-UMIN000014408JSCT62